Despite these differences, official guidelines in Australia too often ignore the impact of sex and gender on health care. For ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the ...

Satellos Bioscience Inc. ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today ...

Canaccord Genuity maintained a Buy rating on Natera (NASDAQ:NTRA) shares, with a price target of $180. Trading at $169.27, the $22.35 billion market cap company enjoys strong analyst support, with a ...

Arrowhead Pharmaceuticals, Inc. ( NASDAQ: ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis ...

GP leaders in Kent have raised concerns around a new electronic referral system developed by the ICB, which could lead to ...

Other writers question Trump's tariffs remembering Canada has long been our ally and question Hochul's budget and some policy ...

When Neurosurgery resident Alexander Tenorio, MD, felt his pager go off in the Trauma Center at UC San Diego Health, the ...

Convulsive therapies are an underappreciated treatment that can alleviate symptoms of severe psychiatric disorders through rapid cycles of muscle contraction ...

In a clinical guideline issued by the American College of Physicians and published online Feb. 4 in the Annals of Internal ...